A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with Schizophrenia

Journal of Clinical Psychiatry

Volumn 62, Issue 11, 2001, Pages 878-883

  Zhang, X Y ^a   Zhou, D F ^a   Zhang, P Y ^a   Wu, G Y ^a   Su, J M ^a   Cao, L Y ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGO BILOBA EXTRACT; HALOPERIDOL; PLACEBO;

ADULT; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCAVENGING SYSTEM; SCHIZOPHRENIA; TOXICITY; TREATMENT OUTCOME;

EID: 0035197073     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n1107     Document Type: Article

References (32)

1. Risperidone: New horizons for the schizophrenic patient
2. Free radical involvement in neuropsychiatric illness
3. Oxygen radicals and neuropsychiatric illness: Some speculations
4. Free radical pathology in schizophrenia: A review
5. Free radical pathology and antioxidant defense in schizophrenia: A review
6. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic depressive patients
7. Enzymes of the antioxidant defense system in chronic schizophrenic patients
8. Peripheral indices of free radical metabolism in schizophrenia
9. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia
10. Elevated plasma lipid peroxides at the onset of nonaffective psychosis
11. Oxidative injury and potential use of antioxidants in schizophrenia
12. An adjunctive role for ascorbic acid in the treatment of schizophrenia?
13. Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid
14. Ginkgo biloba for cerebral insufficiency
15. A double-blind, placebo controlled study of Ginkgo biloba extract ("tanakan") in elderly outpatients with mild to moderate memory impairment
16. A rating scale for depression
17. The Brief Psychiatric Rating Scale
18. Ginkgo biloba for cerebral insufficiency
19. Brain dopamine receptors
20. Choice of neuroleptics based on in vitro pharmacology
21. Dopaminergic cell death in Parkinson's disease
22. Side-effects of psychotropic therapy
23. Dose-dependent effects of Ginkgo biloba extract on cerebral, mental and physical efficiency: A placebo controlled double blind study
24. In vivo studies with EGb 761
25. The relationship between blood SOD concentration and psychopathology in chronic schizophrenic patients
26. The effect of extract of Ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia
27. Free radical mechanisms in schizophrenia and tardive dyskinesia